Sec. 562.015. DISPENSING DIRECTIVE; COMPLIANCE WITH FEDERAL LAW. (a) The board shall adopt rules to provide a dispensing directive to instruct pharmacists on the manner in which to dispense a drug or biological product according to the contents of a prescription. The rules adopted under this section must:
(1) require the use of the phrase "brand necessary" or "brand medically necessary" on a prescription form to prohibit the substitution of a generically equivalent drug or interchangeable biological product for a brand name drug or biological product;
(2) be in a format that protects confidentiality as required by the Health Insurance Portability and Accountability Act of 1996 (Pub. L. No. 104-191) and its subsequent amendments;
(3) comply with federal and state law, including rules, with regard to formatting and security requirements;
(4) be developed to coordinate with 42 C.F.R. Section 447.512; and
(5) include an exemption for electronic prescriptions as provided by Subsection (b).
(b) The board shall provide an exemption from the directive adopted under this section for prescriptions transmitted electronically. The board may regulate the use of electronic prescriptions in the manner provided by federal law, including rules.
Added by Acts 2001, 77th Leg., ch. 1254, Sec. 7, eff. Sept. 1, 2001.
Amended by:
Acts 2015, 84th Leg., R.S., Ch. 1007 (H.B. 751), Sec. 13, eff. September 1, 2015.
Structure Texas Statutes
Subtitle J - Pharmacy and Pharmacists
Chapter 562 - Practice by License Holder
Subchapter A. Prescription and Substitution Requirements
Section 562.002. Legislative Intent
Section 562.003. Disclosure of Price; Patient's Option
Section 562.004. Prescription Transmitted Orally by Practitioner
Section 562.005. Record of Dispensed Drug or Biological Product
Section 562.0051. Communication Regarding Certain Dispensed Biological Products
Section 562.0061. Other Prescription Information
Section 562.0062. Required Statement Regarding Medication Disposal
Section 562.008. Generic Equivalent or Interchangeable Biological Product Authorized
Section 562.012. Substitution of Dosage Form Permitted
Section 562.013. Applicability of Subchapter
Section 562.014. Narrow Therapeutic Index Drugs
Section 562.0141. Transplant Immunosuppressant Drug Product Selection Prohibited
Section 562.0142. Adoption of Rules
Section 562.015. Dispensing Directive; Compliance With Federal Law
Section 562.016. List of Approved Interchangeable Biological Products